A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Clinical trial NCT03412747 · COMPLETED

Trial details

NCT number: NCT03412747
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Plaque Psoriasis Moderate to Severe Plaque Psoriasis

Start date: 2018-01-26
Primary completion: 2019-02-07
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.